Sandoz US News

sandoz_us_news.jpg

Sandoz obtains rights in US to commercialize KERYDINTM (tavaborole) topical solution, 5% from Anacor Pharmaceuticals, Inc.

Princeton, New Jersey, July 21, 2014 – Sandoz today announced an agreement with Anacor Pharmaceuticals, Inc. to obtain exclusive rights to commercialize Anacor’s drug KERYDINTM (tavaborole) topical solution, 5% in the US, through its branded dermatology business, PharmaDerm.

Sandoz launches authorized generic version of TOBI®

Sandoz today announced the US market introduction of tobramycin inhalation solution, USP, an authorized generic version of TOBI®, currently marketed by Novartis Pharmaceuticals Corporation.

Sandoz launches authorized generic of Diovan® in the US

Sandoz today announced the US introduction of an authorized generic version of Diovan® (valsartan) tablets for the treatment of high blood pressure (HBP).

Sandoz Multimedia

Multimedia_Center_300x77.jpg

Visit our multimedia gallery to learn about Sandoz.

Product Catalog

Use our Product Catalog tool to search our database for information regarding a specific Sandoz product in the US.

Sandoz Careers

sandoz_careers.jpg

Our people are our greatest resource. We are always looking for new colleagues to share in our passion and commitment to making the world a healthier place.

Slideshow Background Images